SKB105 for Injection in Advanced Solid Tumors

NCT07380386 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SKB105 for injection Monotherapy

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.